Letter from Secretary Xavier Becerra rejecting appeal of the NIH rejection of the Xtandi petition, February 5, 2024
Government Funded research
KEI Comment to NIST on Transparency of March-in Proceedings
On December 8, 2023, the National Institute of Standards and Technology (NIST) issued a Request for Information regarding the “Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights” (88 FR 85593). Today KEI submitted comments to NIST regarding… Continue Reading
EB 154: KEI statement on WHO’s work in health emergencies
On 25 January 2024, Knowledge Ecology International (KEI) delivered this statement on WHO’s work in health emergencies. There is an ongoing need to make investments in countermeasures to tackle possible pandemics. The current systems of incentives for drug development are… Continue Reading
Prostate cancer patients ask Secretary Beccera to act on their appeal of rejection of the Xtandi march in and government use petititon
On December 19, 2023, three prostate cancer patients, Robert Sachs, Clare Love and Eric Sawyer, sent a letter to Secretary Becerra asking that he act on their appeal of the rejection of their petition, asking the federal government to use… Continue Reading
A quick FAQ on Bayh-Dole Act march-in rights
For journalists writing about march-in rights today, this is how it works. If you get money from the federal government for the R&D leading to an invention, there is typically a contract that gives the funder certain rights in any… Continue Reading
WIPO CDIP 31: Opening statement of Brazil
On Monday, 27 November 2023, Brazil delivered the following general statement at WIPO’s Thirty-First Session of the Committee on Development and Intellectual Property. The statement was delivered by Ambassador Guilherme Patriota, one of the architects of WIPO’s Development Agenda. General… Continue Reading
KEI and Public Citizen Joint Comments on NIH License to Leyden for Coronavirus Treatment
On November 3, 2023, Knowledge Ecology International (KEI) and Public Citizen (PC) submitted joint comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of Exclusive Patent Commercialization License: Human Monoclonal Antibodies That Broadly Target Coronaviruses” (88 FR… Continue Reading
INB 7: Written statement by Knowledge Ecology International
INB 7 Written statement by Knowledge Ecology International November 2023 The current draft of the pandemic accord includes provisions on limitations and exceptions to intellectual property rights that while well intentioned, are problematic. Parties do not need to refer to… Continue Reading
INB 7: Oral statement by Knowledge Ecology International
On Monday afternoon, 6 November 2023, Knowledge Ecology International (KEI) delivered the following oral statement (in person) at the 7th meeting of the World Health Organization’s (WHO) Intergovernmental Negotiating Body (INB). INB 7 Oral statement by Knowledge Ecology International 6… Continue Reading
Save the date – 30 October 2023 – KEI roundtable on the advanced, unedited INB pandemic treaty text (October 2023 version)
Focused discussions on article 9 (Research and development) and article 11 (Transfer of technology and know-how) Monday,30 October 2023 15h30 UTC to 17h30 UTC 16h30 CET to 18h30 CET 11h30 EDT to 13h30 EDT On Monday, 30 October 2023, KEI… Continue Reading